Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
about
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesisLong non-coding RNAs in colorectal cancerRole of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLSingle-nucleotide polymorphisms among microRNA: big effects on cancer.Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphomaSerum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomasMicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.Complete characterization of the microRNAome in a patient with acute myeloid leukemiaEpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis.A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignanciesMicroRNA signatures in B-cell lymphomas.D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingMicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma.MicroRNAs in diffuse large B-cell lymphoma.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesRegulation of B-cell development and function by microRNAs.CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.The coming of age of microRNA for B cell lymphomas.Role of microRNAs in lymphoid biology and disease.The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictionsGuidelines on Designing MicroRNA Sponges: From Construction to Stable Cell Line.MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuseMicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.Micro-RNA Expression and Function in Lymphomas.Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP.miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
P2860
Q54833249-E0618EB2-7062-4C14-B397-35DD6F8A295AQ54834955-987F75F3-4D28-4667-8BDD-30D530CBB9DDQ54896490-D8C670AC-5153-4288-995F-6C9F29C4B621Q54899481-D28166B3-B8FD-46F0-A371-D96418304F7CQ54899500-A0027494-CE14-4A37-928B-AC0F6DBD467CQ54931148-E5ED5AB6-A87E-4703-8874-7BC4458F5236Q54931149-77D4FB52-0AA2-467E-A185-C48A3E25C4B4Q54931759-4F043296-5636-4F0A-B212-DF4501BC3726Q54931770-269A6164-81A3-4E57-882D-3CADD36A85B8Q54931771-2B291900-DF0D-4FB2-BFBD-C3F34882B735Q54931773-7BE79555-832E-45E2-87F1-C915D4B309BBQ54931774-CA5B3F79-6A2F-4075-AFCC-35B2608B869DQ54931777-3DE1956B-AA91-4835-8776-2660E29E84C0Q54931778-4BD66608-782F-4547-910B-58106822079BQ54947249-B5B6B0E7-B7F3-462C-8C83-7D14ADA85974Q54949416-B72C026B-3B2B-42B5-9B11-936F0096529AQ54970706-00D29B09-F68D-4D52-A59E-FB820F5A275DQ54970713-5C3DD575-6C7E-4144-BDD0-3086DCE23102Q54970717-F7F3D2F6-C273-44B1-B0BD-98E7D61E3624Q54970720-A6D6C85E-C2D1-4067-BD57-277243ABED90Q54970721-FF635ED0-607A-437B-8A06-0CFDD1D40918Q54970722-5D973877-BA16-4E05-A967-EBA13DFC89CFQ54970731-32E16A8A-8893-41EE-8911-5BAB70F7CCE4Q54970733-580A18AC-5842-4198-B876-684EFCB67E26Q54972777-22E227A3-B37C-4C25-9932-B1C7820B96CFQ54991853-2B40741B-9918-4CA3-8891-E76DB439AB82Q54994492-F2F433BE-F521-43E1-855A-AE6C28CFD811
P1343
Q24624863-8D9F2DA6-621E-4B1B-912D-C647D39794E9Q26774282-4A1B985F-A6FA-402F-B2CF-2F846CCD6AFFQ27016561-D4282DA8-083E-490E-8CC2-97FD5F9AD521Q27320446-5D732324-A212-432E-BDBB-7B19CD4A73DEQ28543490-1D81BAC4-511C-46B1-B67B-D4D608AEB758Q33579702-8ECF0DDC-E691-468C-8F38-9B6D24F819A9Q33800442-7AD75850-B6DD-4290-9ECB-51D6B2CCBE44Q33893875-A9104575-91D7-4EE4-9E13-D0694724930EQ33940931-E6FFB5BA-119B-4B80-9E49-0519BFA6BAEEQ34234677-2A3FB7E4-E64B-4516-9E29-A59F041EBC86Q34450485-0FE9BF40-3014-4CB6-8868-B6EDE3FFFDCAQ34691519-675EBB8D-9E24-47E9-BC82-F84B44F0B138Q34775356-7C1A5B10-8ACE-45FB-8EF2-FD15206AAB0BQ35051842-CD0FBA77-EE36-4014-9533-E4EB7BAA402EQ35348314-FEA869EE-6DAA-4720-8CB1-EB7E0F968342Q35783359-42A5CC91-57FC-4169-903A-D67CB741948EQ35889016-6C3DEFC8-BFB0-4A90-B8BE-3A536FD7D892Q35909668-C05C7538-455F-46EB-8284-C36F6F6F2AB0Q35974211-DE9B158B-D8B5-4288-8590-7431149F5BB3Q36295294-9EBDE7F8-6684-4E7A-A05D-02BE411ED322Q36524472-103A956F-FE42-42FA-9816-6A3F22FA1F8FQ36602853-A06335A4-F27B-48B9-A182-C0B01F7484CAQ36939328-70802D4E-1E61-41E6-845A-792CECB59C77Q37138668-AD92A2C2-4FC2-4490-85CF-BE99727053A1Q37831954-E853C427-5FA0-4AC0-8393-580B99B2AC15Q37868870-0962205B-3F03-4234-808A-089756453480Q37996436-FC06450B-15B9-4AAD-9F3B-62796D406593Q38022591-A46AC151-EE8B-430B-9826-12304909DB26Q38732127-8017AA62-53CD-4B43-B851-E00B228A7371Q38881957-E148D69E-A2AC-4DDA-987B-90DDFDABFA81Q39281793-F9A79819-29CD-4571-8293-A19670680234Q39452113-240B62CB-0923-44E3-B579-E2890FABC327Q39580400-DD74C1A2-FE79-4514-AD10-271ECF779DAAQ42703031-6A035CF4-B4B5-4A56-B233-58AE76B5D8B4Q53368987-3794555D-3F85-44C2-8723-8493B68EB609Q53618163-A042ABA1-AD51-4DDE-A5D7-296217BFB006Q54323506-95D2F0A9-565A-4E92-9204-03AAE2A4D60E
P2860
Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@en
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@nl
type
label
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@en
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@en
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P4510
P1433
P1476
Copy number abnormalities, MYC ...... diffuse large B-cell lymphoma.
@en
P2093
Aswani R Bolla
Deepak Rai
Marsha C Kinney
Ricardo C T Aguiar
Ryan S Robetorye
Sang-Woo Kim
Siddharth Adhvaryu
P2860
P304
P356
10.1182/BLOOD-2009-01-202028
P407
P577
2009-03-10T00:00:00Z